IL6 and neoplasm: Activation of IL-6/STAT3 impairs dendritic cell antigen presentation, reduces T cell responses, and promotes the accumulation of immunosuppressive cell populations such as regulatory T cells and myeloid-derived suppressor cells, fostering an immunosuppressive tumor microenvironment (88, 89).